Ancora Advisors’s Silicon Laboratories SLAB Stock Holding History

Ancora Advisors’s Portfolio SLAB Stock Details SLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13	Closed	-$2K	–	1934
2022 Q3	$2K	Hold	13	–	–	﹤0.01%	1818
2022 Q2	$2K	Buy	+13	New	+$1.82K	﹤0.01%	1973
2021 Q3	–	Sell	-41	Closed	-$6K	–	2285
2021 Q2	$6K	Buy	+41	New	+$5.73K	﹤0.01%	1665

Other funds holding SLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ancora Advisors's SLAB Position: Q4 2022 in Review

Ancora Advisors sold out of Silicon Laboratories (SLAB) in Q4 2022, closing a stake of 13 shares — an estimated $2K sold.

Ancora Advisors first reported a position in SLAB in Q2 2021 and held it in 3 quarters. The position peaked at $6K in Q2 2021. 310 funds tracked by Wall St. Rank hold SLAB as of Q4 2022.

Ancora Advisors reported no remaining Silicon Laboratories position as of Q4 2022 after selling out during the quarter.
Ancora Advisors sold 13 Silicon Laboratories shares in Q4 2022, an estimated $2K.
Ancora Advisors first reported a position in Silicon Laboratories in Q2 2021 and held it in 3 quarters.
Ancora Advisors's Silicon Laboratories position peaked at $6K in Q2 2021.
310 funds tracked by Wall St. Rank held Silicon Laboratories as of Q4 2022.

Based on Ancora Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.